Skip To Main Content
Koji Shimomura on Muck Rack

Koji Shimomura

As seen in: Pharma Japan
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Koji

Contact Koji, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

BMS Prods Japan to Better Reward Regenerative Medicine Innovation

|
By Koji Shimomura, Ken Yoshino, Philip Carrigan
| Pharma Japan
Bristol Myers Squibb is calling on Japan to create a more attractive and predictable market environment that appropriately rewards innovation in regenerative medicine as the US drug maker looks to bolster its R&D capabilities in the country. Speaking at a… To read the full story
Open in Who Shared Issue with article?

Sandoz Readies Multiple Biosimilar Launches in Japan for 2027

|
By Koji Shimomura, Ken Yoshino, Philip Carrigan
| Pharma Japan
Sandoz is preparing to launch multiple new biosimilars in Japan in 2027 as the Swiss drug maker moves to sharply expand its global biosimilar portfolio under a new long-term growth strategy. “We will move forward with plans to launch new… To read the full story
Open in Who Shared Issue with article?

Sumitomo Pharma Goes Global with Adjuvants, Targets 100 Billion Yen

|
By Koji Shimomura, Philip Carrigan, Shinya Sato
| Pharma Japan
By Philip Carrigan We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Open in Who Shared View Duplicates (4) Issue with article?
See all 87 articles